Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Central European Journal of Urology
|
April 8, 2014
When do we need a prophylactic treatment for asymptomatic bacteriuria?
Thorsten H Ecke
Urologie (Heidelberg, Germany)
|
May 21, 2025
[Successful implementation of screening for urothelial carcinoma of the upper and lower urinary tract-a critical evaluation of urine-based lateral flow tests]
Thorsten H Ecke
Central European Journal of Urology
|
April 8, 2014
We need to know the treatment of urethral of injuries
Thorsten H Ecke
Advances in Experimental Medicine and Biology
|
November 5, 2015
Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer
Thorsten H Ecke
International Journal of Molecular Sciences
|
March 4, 2020
Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?
Thorsten H Ecke, Thomas Otto
Urologie (Heidelberg, Germany)
|
August 23, 2024
[New therapeutic approaches for non-muscle invasive bladder cancer-is organ preservation also possible after BCG (Bacillus Calmette Guérin)?]
Thorsten H Ecke, Georgios Gakis
International Journal of Molecular Sciences
|
November 22, 2017
Illumination of a Vision-How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research
Thorsten H Ecke, Thomas Otto
Cases Journal
|
February 3, 2009
Multimodal stone therapy for two forgotten and encrusted ureteral stents: a case report
Thorsten H Ecke, Steffen Hallmann, Jürgen Ruttloff
Frontiers in Oncology
|
July 20, 2023
Editorial: Identifying novel biomarkers in bladder cancer
Thorsten H Ecke, Yair Lotan, Thierry Massfelder
Anti-Cancer Drugs
|
August 24, 2012
Targeted agents in second-line bladder cancer therapy
Holger Gerullis, Thomas Otto, Thorsten H Ecke
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Central European Journal of Urology
|
April 8, 2014
When do we need a prophylactic treatment for asymptomatic bacteriuria?
Thorsten H Ecke
Urologie (Heidelberg, Germany)
|
May 21, 2025
[Successful implementation of screening for urothelial carcinoma of the upper and lower urinary tract-a critical evaluation of urine-based lateral flow tests]
Thorsten H Ecke
Central European Journal of Urology
|
April 8, 2014
We need to know the treatment of urethral of injuries
Thorsten H Ecke
Advances in Experimental Medicine and Biology
|
November 5, 2015
Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer
Thorsten H Ecke
International Journal of Molecular Sciences
|
March 4, 2020
Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?
Thorsten H Ecke, Thomas Otto
Urologie (Heidelberg, Germany)
|
August 23, 2024
[New therapeutic approaches for non-muscle invasive bladder cancer-is organ preservation also possible after BCG (Bacillus Calmette Guérin)?]
Thorsten H Ecke, Georgios Gakis
International Journal of Molecular Sciences
|
November 22, 2017
Illumination of a Vision-How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research
Thorsten H Ecke, Thomas Otto
Cases Journal
|
February 3, 2009
Multimodal stone therapy for two forgotten and encrusted ureteral stents: a case report
Thorsten H Ecke, Steffen Hallmann, Jürgen Ruttloff
Frontiers in Oncology
|
July 20, 2023
Editorial: Identifying novel biomarkers in bladder cancer
Thorsten H Ecke, Yair Lotan, Thierry Massfelder
Anti-Cancer Drugs
|
August 24, 2012
Targeted agents in second-line bladder cancer therapy
Holger Gerullis, Thomas Otto, Thorsten H Ecke
Page
of 8